Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Saxagliptin add-on to dapagliflozin and metformin in type 2 diabetes mellitus
2014-003788-39Phase 4Completed
- Sponsor
- Profil
- Start
- Oct 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of saxagliptin, dapagliflozin and metformin in type 2 diabetes mellitus (T2DM) (2 arms), sponsored by Profil. Started Oct 2014; status: completed.
02
Drugs
saxagliptindapagliflozinmetformin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2014-003788-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-003788-39.